ALK ligand ALKAL2 potentiates MYCN‐driven neuroblastoma in the absence of ALK mutation

High‐risk neuroblastoma (NB) is responsible for a disproportionate number of childhood deaths due to cancer. One indicator of high‐risk NB is amplification of the neural MYC (MYCN) oncogene, which is currently therapeutically intractable. Identification of anaplastic lymphoma kinase (ALK) as an NB o...

Повний опис

Бібліографічні деталі
Автори: Borenäs, Marcus, Umapathy, Ganesh, Lai, Wei‐Yun, Lind, Dan E, Witek, Barbara, Guan, Jikui, Mendoza‐Garcia, Patricia, Masudi, Tafheem, Claeys, Arne, Chuang, Tzu‐Po, El Wakil, Abeer, Arefin, Badrul, Fransson, Susanne, Koster, Jan, Johansson, Mathias, Gaarder, Jennie, Van den Eynden, Jimmy, Hallberg, Bengt, Palmer, Ruth H
Формат: Online Стаття Текст
Мова:English
Опубліковано: John Wiley and Sons Inc. 2021
Предмети:
Articles
Онлайн доступ:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849294/
https://www.ncbi.nlm.nih.gov/pubmed/33411331
http://dx.doi.org/10.15252/embj.2020105784

Інтернет

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849294/
https://www.ncbi.nlm.nih.gov/pubmed/33411331
http://dx.doi.org/10.15252/embj.2020105784

Схожі ресурси